Latest Mergers And Acquisitions News

EQ Resources Ltd has agreed to acquire six exploration permits near its Mt Carbine tungsten mine for A$250,000, aiming to expand its regional resource pipeline and support a hub-and-spoke processing model.

Aeris Resources continues to hit significant high-grade gold intersections at its Golden Plateau deposit, validating its geological model and setting the stage for a resource update in FY27.

Horizon Oil confirms its takeover offer for Cue Energy shares as best and final, holding a majority stake and with all regulatory approvals cleared. The offer period closes on 19 June 2026, with liquidity risks flagged for minority shareholders who abstain.

Dart Mining has agreed to sell four Victorian projects to Indigo Metals for $7.1 million, combining cash, shares, and a royalty on antimony production, tying its fortunes to Indigo’s upcoming ASX debut.

Diamond Infraco has officially satisfied multiple regulatory conditions in its takeover offer for Atlas Arteria, freeing the offer from several major hurdles and holding a 34.56% stake.

Medallion Metals has completed front-end engineering for the Cosmic Boy Concentrator refurbishment and secured a $7.6 million early works contract, keeping commissioning on track for Q2 2027.

American West Metals has struck a significant continuous 108.4m interval of high-grade indium mineralisation at its West Desert Project, expanding the known resource and confirming a large-scale skarn system with zinc, gold, silver, and copper by-products.

Lakes Blue Energy reports promising pressure build-up and confirms extensive gas-bearing sands at Wombat-5, targeting enhanced perforation and flow testing in late August 2026.

Forrestania Resources has launched a recommended off-market takeover bid for Zenith Minerals, valuing Zenith at about A$93.5 million with a 46.7% premium. The deal aims to create a larger, diversified Western Australian gold explorer and developer.

OD6 Metals has exercised its option to acquire the Quinn Fluorspar Project in Nevada after validating multiple high-grade fluorspar zones and historical data, positioning itself to tap into critical US mineral demand.

LTR Pharma has secured a binding US telehealth commercialisation framework for its intranasal erectile dysfunction treatment ROXUS, committing to at least 150,000 prescriptions in the first year and granting exclusivity to Shed Holdings' platform.

Minerals 260 continues to hit high-grade gold intercepts at its Bullabulling Project, underpinning resource upgrades and advancing production readiness ahead of key feasibility milestones.